A federal judge in Florida dismissed New York-based Oscar Health’s lawsuit against Blue Cross Blue Shield (BCBS) of Florida over broker arrangements, according to a Friday, September 20, ruling.
Judge Paul Byron of the Middle District Court of Florida granted a motion to dismiss Oscar’s lawsuit, ruling that BCBS Florida’s exclusive broker arrangements fall within the purview of state law.
“Florida Blue’s efforts at enforcing a lawful contract are not coercive, regardless of the tone or tenor of the language employed by Florida Blue,” Byron wrote in his judgment.
This marks the second legal defeat for Oscar against BCBS Florida after Judge Byron ruled in February that the company could use its brokers following Oscar’s request for an injunction.
Oscar first filed the suit in November 2018, challenging BCBS Florida’s broker arrangements were “improper, unlawful, and anticompetitive,” and designed to reduce competition in the Sunshine State’s insurance markets created under the Affordable Care Act (ACA).
The company further asserted that BCBS Florida required brokers to sign exclusivity agreements to only sell BCBS’ individual ACA plans and keep Oscar out of the market.
Full Content: HealthCare Dive
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Brazil’s Antitrust Watchdog Expected to Approve Pet Retail Merger Without Conditions
May 20, 2025 by
CPI
EU and UK Finalize Deal to Strengthen Antitrust Cooperation
May 20, 2025 by
CPI
Clemens Food Group Reaches $13.5 Million Settlement in Pork Price-Fixing Suit
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas